Data indicate pre-existing lamivudine resistance predisposes patients to higher rates of BARACLUDE resistance. Nucleoside-naive patients experienced a cumulative probability of genotypic resistance of 1.2% through five years.
A survey by CancerCare found that while many women know about breast cancer, few are aware of recent treatment advances. The majority would actively work with their doctor to identify proper treatment, but 86% were uncertain about what questions to ask.
Experts Chris Mooney and Matthew Nisbet argue that scientists should apply research on framing and other social sciences to improve their communication skills. By shaping public perception of complex issues, scientists can make knowledge more personally relevant to diverse segments of the public.
Chronic pain has increased by 26% among US workers over the past decade, with most employees experiencing moderate to severe pain while still attending work. Employers are encouraged to invest in workplace wellness programs addressing chronic pain, as only 22% currently include such components.
Zaditor offers up to 12 hours of continuous itch relief with one drop, a significant improvement over most OTC products that only provide 3-4 hours of short-term relief. The medication is safe for use in children as young as three and does not contain decongestants that can cause rebound redness.
New data from the largest study on CML patients (1106) showed improved rates of progression-free survival and durable responses to imatinib. Patients with early cytogenetic responses achieved higher progression-free survival rates, with 93% at 42 months compared to 74% without
A subanalysis of a broader study found that patient-controlled, transdermal pain management system IONSYS TM provided similar pain relief to IV PCA morphine after gynecologic surgery. The study showed no significant differences in overall pain control, supplemental medication use, or adverse events between the two groups.
A new study published in Critical Care Medicine found that immune-enhancing therapy significantly reduces infection rates and shortens hospitalization length by nearly three days. The therapy was most beneficial for surgical patients, with no adverse effects observed.